Business
Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation
SOUTH SAN FRANCISCO, Calif., January 28, 2026--Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co‑led by investment funds managed by BlackRock and Eclipse, bringing the company’s total capital raised to $612 million.
About this update from Blackrock, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":251,"url":"https://media.zenfs.com/en/business-wire.com/2c73f736ccf4fcbe2a2d84ea1c1ad59c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kTh7iULTHJ10ecrFpEkFzQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUwMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/2c73f736ccf4fcbe2a2d84ea1c1ad59c","width":480,"height":251}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2262,"height":798,"url":"https://media.zenfs.com/en/business-wire.com/739360a392f6619f7ea4453524dfd554"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/DMieqkxx9399mOwJEWWgIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzOTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/739360a392f6619f7ea4453524dfd554","width":960,"height":339},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/StjdbS4XPL_1t9cnNqIcdw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04NDY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/739360a392f6619f7ea4453524dfd554","width":1200,"height":423}}},{"type":"list","items":[{"val":[{"type":"text","content":"New investors include T. Rowe Price Investment Management, Inc., Baillie Gifford, Duquesne Family Office, Intuitive Ventures, EDBI, and Gates Frontier","length":150,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Funding enables global commercial launch and unconstrained supply of cell therapies, expanding access to hundreds of thousands of patients annually","length":147,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":297,"olType":false},{"type":"text","content":"SOUTH SAN FRANCISCO, Calif., January 28, 2026--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co‑led by investment funds managed by BlackRock and Eclipse, bringing the company’s total capital raised to $612 million.","length":317,"tagName":"p"},{"type":"text","content":"The Series D adds a new group of leading global investors, including accounts advised by T. Rowe Price Investment Management, Inc., Baillie Gifford, Duquesne Family Office, Intuitive Ventures, EDBI, and Gates Frontie...